Mouse Anti-Rankl Antibody Mw

Description: TRANCE, also known as RANK ligand, is a type II membrane protein belonging to the tumor necrosis factor superfamily and has been designated TNFSF11.

Description: Rabbit polyclonal to RANKL.

Description: RANKL is a protein encoded by the TNFSF11 gene which is approximately 35,4 kDa. RANKL isoform 1 and 3 are localised to the cell membrane and isoform 2 is localised to the cytoplasm. It is involved in PEDF induced signalling, ERK signalling, RANK signalling in osteoclasts and Akt signalling. This protein falls under the tumour necrosis factor cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. It has been shown to be a dendritic cell survival factor and is involved in the regulation of T cell-dependent immune response. RANKL is expressed highest in the peripheral lymph nodes. Mutations in the TNFSF11 gene may result in osteopetrosis. STJ96769 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of RANKL protein.

Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain).

Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain).

Description: TRANCE (receptor activator of NFκB ligand [RANK L], also called TNF-related activation-induced cytokine [TRANCE], osteoprotegrin ligand [OPGL], and osteoclast differentiation factor [ODF]), is a member of the tumor necrosis factor (TNF) family. TRANCE was originally identified as an immediate early gene upregulated by T cell receptor stimulation. The murine TRANCE cDNA encodes a type II transmembrane protein of 316 amino acids with a predicted cytoplasmic domain of 48 amino acids and an extracellular domain of 247 amino acids. The extracellular domain contains two potential N-linker glycosylation sites. Mouse and human TRANCE share 85% amino acid identity. TRANCE is primarily expressed in T cells and T cell rich organs, such as thymus and lymph nodes. The multifunctions of TRANCE include induction of activation of the c-jun N-terminal kinase, enhancement of T cell growth and dendritic cell function, induction of osteoclastogenesis, and lymph node organogenesis. RANK is the cell surface signaling receptor of TRANCE. RANK has been shown to undergo receptor clustering during signal transduction. Osteoprotegrin, a soluble member of the TNF receptor family which binds TRANCE, is a naturally occurring decoy receptor that counterbalances the effects of TRANCE.

Description: Affinity purified Rabbit polyclonal RANKL antibody

Description: Affinity purified Rabbit polyclonal RANKL antibody

Description: WB,IHC,IF/ICC,ELISA(peptide)

Description: WB,IHC,IF/ICC,ELISA(peptide)

Description: WB,IF/ICC,ELISA(peptide)

Description: WB,IF/ICC,ELISA(peptide)

Description: WB,IHC,IF/ICC,ELISA(peptide)

Description: WB,IHC,IF/ICC,ELISA(peptide)

Description: RANKL Rabbit Polyclonal Antibody

Description: RANKL Rabbit Polyclonal Antibody

Description: RANKL Rabbit Polyclonal Antibody

Description: RANKL Rabbit Polyclonal Antibody

Description: Available in various conjugation types.